FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072600 [Registered on: 16/08/2024] Trial Registered Prospectively
Last Modified On: 08/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Greeva Basti (Moolak Taila) and Raktamokshan (Wet cupping) In The Management of Manyastambha (Cervical Spondylosis) 
Scientific Title of Study   A Comparative Clinical Study To Evaluate The Effficacy Of Greeva Basti (Moolak Taila) With Intermittent Raktmoskhan (Wet Cupping) And Only Greeva Basti (Moolak Taila) In The Management Of Manyastambha W.S.R Cervical Spondylosis 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Megha Agarwal 
Designation  MD Scholar 
Affiliation  Post Graduate Institute of Ayurved 
Address  PG Department of Panchkarma Post Graduate Institute of Ayurved Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan India

Jodhpur
RAJASTHAN
342037
India 
Phone  7597278971  
Fax    
Email  megha.agar1995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Gyan Prakash Sharma 
Designation  Associate Professor & HOD 
Affiliation  Post Graduate Institute of Ayurved 
Address  PG Department of Panchkarma Post Graduate Institute of Ayurved Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan India

Jodhpur
RAJASTHAN
342037
India 
Phone  9829798701  
Fax    
Email  atreyagyan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Megha Agarwal 
Designation  MD Scholar 
Affiliation  Post Graduate Institute of Ayurved 
Address  PG Department of Panchkarma Post Graduate Institute of Ayurved Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Campus Kadvad Jodhpur Rajasthan India

Jodhpur
RAJASTHAN
342037
India 
Phone  7597278971  
Fax    
Email  megha.agar1995@gmail.com  
 
Source of Monetary or Material Support  
Post Graduate Institute of Ayurved Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur 342037 Rajasthan INDIA 
 
Primary Sponsor  
Name  Post Graduate Institute of Ayurved DSRRAU Jodhpur 
Address  PG Department of Panchkarma Post Graduate Institute of Ayurved DSRRAU Jodhpur 342037 Rajasthan INDIA 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Megha Agarwal  Post Graduate Institute of Ayurved DSRRAU Jodhpur  PG Department of Panchkarma Post Graduate Institute of Ayurved DSRRAU Jodhpur Nagaur Road Kadwad Jodhpur Rajasthan 342037 INDIA
Jodhpur
RAJASTHAN 
7597278971

megha.agar1995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee Post Graduate Institute of Ayurved  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M478||Other spondylosis. Ayurveda Condition: MANYASTAMBAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-grIvAbastiH, ग्रीवाबस्तिः (Procedure Reference: Yog Ratnakar Chikitsa 25, Procedure details: 20 Patients will be treated with Greeva Basti with Moolak Taila)
(1) Medicine Name: Moolak Taila, Reference: Charak Chikitsa 28, Route: Topical, Dosage Form: Taila, Dose: 350(ml), Frequency: od, Duration: 14 Days
2Comparator ArmProcedure-raktamokShaNam/ SoNitasrAvaH/ asravisrutiH/ SastravisrAvaNam, रक्तमोक्षणम्/ शोणितस्रावः/ अस्रविस्रुतिः/शस्त्रà (Procedure Reference: Sushrut Sutra 13, Procedure details: 20 Patients will be treated with Greeva Basti with Moolak Taila & intermittent Raktmokshana)
(1) Medicine Name: Moolak Taila, Reference: Charak Chikitsa 28, Route: Topical, Dosage Form: Taila, Dose: 350(ml), Frequency: od, Duration: 15 Days
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Diagnosed and confirmed cases of Manyastambha (Cervical Spondylosis) as per case report on the basis of sign and symptoms

Patients between the age group of 18 to 65 years of either sex religion and occupation

Patients willing to give written consent
 
 
ExclusionCriteria 
Details  Pregnant and lactating woman

Subjects contraindicated for Greeva basti and Raktmokshana

Stenosis of spinal canal and myelopathy

Patients suffering with other systemic chronic disorders like malignancy and cardiac and renal disease and also diabetic patients

Ankylosing spondylitis adhesive capsulitis fracture and dislocation involving shoulder joint

Patient having HIV and HEPATITIS infection
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To see the effect on subjective and objective parameters  30 Days 
 
Secondary Outcome  
Outcome  TimePoints 
To see any other effects of drug and procedures  30 Days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Study Type - Interventional 

Number Of Patients- 40(20 Patients in each group)

Type of study- Open Labelled

Duration of study- 30 Days

Follow Up- For Group A :- Total duration of treatment 30 days including 15 days follow up (1st Day Cupping and 1 to 7 Days Greeva Basti then 8th  day cupping then 9 to 15 days Greeva Basti and 15th day Cupping
                  For Group B :- Total duration of treatment 28 days including 14 days Greeva Basti and 14 days follow up 
 
Close